Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

Background<br/> In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving a potential window for vertical transmission. Insights into HBV seroprevalence in the vulnerable HIV-infected group are important to drive improvements in surveillance, treatment and prevention...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Jooste, P, van Zyl, A, Adland, E, Daniels, S, Hattingh, L, Brits, A, Wareing, S, Goedhals, D, Jeffery, K, Andersson, M, Goulder, P, Matthews, P
Materialtyp:	Journal article
Publicerad:	Elsevier 2016

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

Liknande verk